Cisplatin, epirubicin, and lonidamine combination regimen as first-line chemotherapy for metastatic breast cancer: a pilot study - Dogliotti, L; Danese, S; Berruti, A; Zola, P; Buniva, T; Bottini, A; Richiardi, G; Moro, G; Farris, A; Bau, M G; Porcile, G (Cancer Chemother Pharmacol, 1998)